Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Olga Hilas"'
Autor:
Sum Lam, Olga Hilas
Publikováno v:
Clinical Interventions in Aging, Vol Volume 2, Pp 337-345 (2007)
Sum Lam1,2, Olga Hilas1,31St. John’s University, College of Pharmacy and Allied Health Professions, Department of Clinical Pharmacy Practice, Queens, New York, USA; 2Division of Geriatric Medicine, Winthrop University Hospital, Mineola, New York, U
Externí odkaz:
https://doaj.org/article/5c98a2c11dfe49b3a67a6dad7fa5080e
Autor:
Regina, Ginzburg, Olga, Hilas
Publikováno v:
The Senior Care Pharmacist. 37:412-420
Avoiding clinical and therapeutic inertia, through pharmacist-led medication therapy management, can lead to avoidance of inappropriate medication use and adverse medication events. Clinical and therapeutic inertia are terms that have been used indis
Autor:
Tina Caliendo, Olga Hilas
Publikováno v:
The Senior care pharmacist. 35(10)
Substance misuse in adults 60 years of age and older is one of the fastest-growing health issues in the United States. Alcohol and prescription drugs are among the most commonly misused agents. With growing concern for opioid-overdose deaths and the
Autor:
Olga Hilas
Publikováno v:
The Senior Care Pharmacist. 35:334-335
Dr. Olga Hilas, associate professor from St. John's University, reflects on her Pain Management Traineeship with the American Society of Consultant Pharmacists Foundation.
Autor:
Olga Hilas, Michele Pisano
Publikováno v:
The Consultant Pharmacist. 31:267-270
According to the National Health and Nutrition Examination Survey III, 35% to 45% of adults 60 years of age or older had zinc intakes below the estimated average requirement of 6.8 mg/day for elderly females and 9.4 mg/day for elderly males. Zinc def
Publikováno v:
PT : a peer-reviewed journal for formulary management. 42(1)
Zarxio (filgrastim-sndz), a biosimilar for the treatment of severe chronic neutropenia.
Autor:
Carmela Avena-Woods, Olga Hilas
Publikováno v:
The Consultant Pharmacist. 29:124-130
Changes in body weight can affect the overall health of an older patient and should not be considered a normal part of the aging process. In particular, weight loss can lead to numerous adverse health outcomes affecting daily activities, loss of func
Publikováno v:
The Open Neurology Journal
Objective: To summarize major clinical trials which evaluate the efficacy and safety data of approved disease modifying agents for the treatment of various types of multiple sclerosis. Data Sources: A MEDLINE (1966 to August 2008) search of clinical